3PC-015 In-use stability of Comirnaty and Spikevax clinical solutions: Pfizer-BioNTech and Moderna COVID-19 vaccines: a comparative study from a hospital pharmacy perspective

Autor: J Hermosilla Fernández, A Alonso-García, R Pérez Robles, A Torrente López, J Ruiz Travé, N Navas, J Cabeza, A Salmerón García
Rok vydání: 2023
Zdroj: Section 3: Production and compounding.
DOI: 10.1136/ejhpharm-2023-eahp.38
Databáze: OpenAIRE